↓ Skip to main content

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis

Overview of attention for article published in Cochrane database of systematic reviews, April 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs
1 blog
twitter
41 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis
Published in
Cochrane database of systematic reviews, April 2022
DOI 10.1002/14651858.cd013846.pub2
Pubmed ID
Authors

Souvik Mitra, Courtney E Gardner, Abigale MacLellan, Tim Disher, Danielle M Styranko, Marsha Campbell-Yeo, Stefan Kuhle, Bradley C Johnston, Jon Dorling

Twitter Demographics

The data shown below were collected from the profiles of 41 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 13%
Other 3 9%
Unspecified 2 6%
Professor 2 6%
Student > Postgraduate 2 6%
Other 6 19%
Unknown 13 41%
Readers by discipline Count As %
Medicine and Dentistry 8 25%
Unspecified 2 6%
Nursing and Health Professions 2 6%
Social Sciences 2 6%
Agricultural and Biological Sciences 1 3%
Other 2 6%
Unknown 15 47%

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2022.
All research outputs
#1,076,083
of 23,306,612 outputs
Outputs from Cochrane database of systematic reviews
#2,404
of 12,448 outputs
Outputs of similar age
#26,589
of 442,574 outputs
Outputs of similar age from Cochrane database of systematic reviews
#34
of 115 outputs
Altmetric has tracked 23,306,612 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,448 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,574 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 115 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.